This Cancer Research Catalyst blog discusses the AACR Project GENIE data analysis presented during the AACR's Annual Meeting 2017.
The American Association for Cancer Research Returns as the Charity Title Partner of the Rock ‘n’ Roll Philadelphia Half Marathon
Stand Up To Cancer Announces Second SU2C Catalyst Collaboration with Genentech
Sir Richard Peto, FRS, to Receive William L. McGuire Memorial Lecture Award at the San Antonio Breast Cancer Symposium
Head and Neck Cancer Recurrence Following Radiation Associated With High Tumor PD-L1 Expression
Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, Sept. 6-9, 2017
Conference on The Science of Cancer Health Disparities, Sept. 25-28, 2017
AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics, Oct. 26-30, 2017
San Antonio Breast Cancer Symposium, Dec. 5-9, 2017
This Cancer Research Catalyst blog post discusses the FDA's first approval of an anticancer therapeutic for use based on the tumor's biomarkers and not the tumor's origin.
The Washington Post reported on this study published in the AACR journal Cancer Epidemiology, Biomarkers & Prevention.